VOYA Investment Management
ZVRA icon

VOYA Investment Management’s Zevra Therapeutics ZVRA Stock Holding History

VOYA Investment Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
+11,255
New +$125K ﹤0.01% 2280
2026
Q1 		– Sell
-10,334
Closed -$92.6K – 2455
2025
Q4 		$92.6K Hold
10,334
– – ﹤0.01% 2275
2025
Q3 		$98.3K Sell
10,334
-5,352
-34% -$53.7K ﹤0.01% 2304
2025
Q2 		$138K Buy
15,686
+864
+6% +$7.01K ﹤0.01% 2410
2025
Q1 		$111K Sell
14,822
-562
-4% -$4.47K ﹤0.01% 2416
2024
Q4 		$128K Buy
15,384
+385
+3% +$3.29K ﹤0.01% 2515
2024
Q3 		$104K Sell
14,999
-1,400
-9% -$9.5K ﹤0.01% 2654
2024
Q2 		$80.4K Buy
16,399
+3,526
+27% +$16.7K ﹤0.01% 2720
2024
Q1 		$74.7K Sell
12,873
-1,990
-13% -$12.2K ﹤0.01% 2676
2023
Q4 		$97.4K Hold
14,863
– – ﹤0.01% 2761
2023
Q3 		$71.6K Hold
14,863
– – ﹤0.01% 2802
2023
Q2 		$75.8K Buy
+14,863
New +$80.1K ﹤0.01% 2856
2022
Q2 		– Sell
-10,899
Closed -$55K – 2905
2022
Q1 		$55K Hold
10,899
– – ﹤0.01% 2586
2021
Q4 		$95K Sell
10,899
-594
-5% -$5.3K ﹤0.01% 2671
2021
Q3 		$107K Hold
11,493
– – ﹤0.01% 2722
2021
Q2 		$147K Buy
+11,493
New +$124K ﹤0.01% 2683

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VOYA Investment Management's ZVRA Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Zevra Therapeutics (ZVRA) in Q2 2026: 11,255 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #2280 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in ZVRA as recently as Q4 2025.

VOYA Investment Management first reported a position in ZVRA in Q2 2021 and has held it in 16 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • VOYA Investment Management held 11,255 shares of Zevra Therapeutics worth $161K as of Q2 2026.
  • Zevra Therapeutics was a new VOYA Investment Management position in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2280 holding.
  • VOYA Investment Management first reported a position in Zevra Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.